Silencing of UBE2Q1 by siRNAs reduces proliferation, induces cell cycle arrest, and upregulates tumor suppressor protein 53 (p53) and cyclin-dependent kinase inhibitor 1 (p21) in HCC cells [33]. Here, CDKN1A is linked to hepatocellular carcinoma.